Clinical Trials · NCT07043361

Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels

Name: Efficacy of Semaglutide in Glycemic Control, Weight Loss, and Improving Lipidogram- Role of Baseline Vitamin D Levels
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ASemaglutide

Phase: N/A
Recruitment status: Completed
Sponsor: Hillel Yaffe Medical Center
Enrollment: 5,300
Start date: Dec 2023
Locations: 1 site, Israel
Primary endpoint: relative weight loss measured by BMI

View Semaglutide compound reference